Stay updated on MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.

Latest updates to the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.3.3) is added, and the HHS Vulnerability Disclosure link along with the prior revision (v3.3.2) are removed. These updates are administrative and do not affect the study information.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows addition of v3.3.2 and removal of v3.2.0, reflecting routine record-keeping rather than changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange Detected- Removed the site-wide banner about a lapse in government funding and NIH/OPM operating status from the page. The core study history content and controls remain unchanged.SummaryDifference0.8%

- Check61 days agoChange DetectedRecord history shows progressive updates: 2021-12-09 adds Study Status and Contacts/Locations. 2022-01-13 and 2022-04-12 update Recruitment Status and Study Status; 2024-01-25 adds an Oversight entry.SummaryDifference0.1%

- Check83 days agoChange DetectedUpgrade notice and new version v3.2.0 added; previous version v3.1.0 removed.SummaryDifference12%

- Check90 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.3%

Stay in the know with updates to MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.